Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01145586Phase 3Completed
Phase 3, randomised, double-blind trial of lactase in lactose intolerance (2 arms), sponsored by Eurofarma. Primary endpoint: Hydrogen value in the expired air. Started Jun 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01145586.